- Home
- / Melodiol Global Health
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Melodiol Global Health financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.1
2024-10-29
Market Capitalization
$131.7 M
2024-10-29
Revenue
$21.6 M
FY, 2023
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| AUD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|---|---|---|
| Revenue | 578.0K | 3.6M | 2.4M | 6.2M | 8.7M | 21.6M |
| Cost of goods sold | 354.0K | 2.0M | 3.2M | 5.0M | 8.4M | 19.5M |
| Gross profit | 225.0K | 2.5M | 303.0K | 1.3M | 542.0K | 2.4M |
| Gross profit margin, % | 67.7% | 12.4% | 20.2% | 6.2% | 10.9% | |
| Operating expense total | 16.3M | 12.2M | 15.4M | 29.3M | 17.5M | 23.4M |
| Depreciation and amortization | 464.0K | 3.4M | 5.0M | 266.0K | 14.5M | 22.1M |
| EBITDA | (16.1M) | (9.7M) | (15.1M) | (28.1M) | (17.0M) | (21.1M) |
| EBITDA margin, % | -267.9% | -617.0% | -451.1% | -195.5% | -97.8% | |
| EBIT | (16.5M) | (13.2M) | (20.1M) | (28.3M) | (31.9M) | (43.2M) |
| EBIT margin, % | -362.9% | -822.7% | -455.4% | -366.7% | -200.4% | |
| Interest income | 144.0K | 57.0K | 84.0K | 679.0K | ||
| Interest expense | 432.0K | 2.1M | 9.3M | 1.7M | 675.0K | 9.9M |
| Pre tax profit | (16.8M) | (15.3M) | (30.8M) | (30.0M) | (32.8M) | (52.4M) |
| Income tax expense | 2.0K | 24.0K | ||||
| Net Income | (16.8M) | (15.3M) | (30.8M) | (30.0M) | (32.8M) | (52.4M) |